Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Alphabet Replaces Verizon in Dow Jones Industrial Average 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
PLEASANTON, Calif., Feb. 24, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jonathan Kennedy, Sr. Vice-President and Chief Financial Officer will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, Florida. Mr. Kennedy is scheduled to present on Wednesday, March 9th at 8:40 a.m. Eastern Time (5:40 a.m. PT).
Investors may listen to a live webcast and view a copy of the slide presentation online via the “Investors” section of the Company’s web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days.
About Natus Medical
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment and neurological dysfunction.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Sr. Vice President Finance and Chief Financial Officer (925) 223-6700 [email protected]
